Kazia Therapeutics Ltd
ASX:KZA
Operating Margin
Kazia Therapeutics Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | AU |
Market Cap | 18.2m AUD |
Operating Margin |
-106 935%
|
Country | US |
Market Cap | 293.9B USD |
Operating Margin |
29%
|
Country | US |
Market Cap | 167.6B USD |
Operating Margin |
24%
|
Country | US |
Market Cap | 115B USD |
Operating Margin |
41%
|
Country | US |
Market Cap | 108.2B USD |
Operating Margin |
30%
|
Country | AU |
Market Cap | 135.3B AUD |
Operating Margin |
26%
|
Country | US |
Market Cap | 84.4B USD |
Operating Margin |
32%
|
Country | US |
Market Cap | 50.9B USD |
Operating Margin |
-100%
|
Country | US |
Market Cap | 43.1B USD |
Operating Margin |
-33%
|
Country | US |
Market Cap | 33.6B USD |
Operating Margin |
22%
|
Country | KR |
Market Cap | 39.7T KRW |
Operating Margin |
30%
|
Profitability Report
View the profitability report to see the full profitability analysis for Kazia Therapeutics Ltd.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Kazia Therapeutics Ltd's most recent financial statements, the company has Operating Margin of -106 935%.